There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Parkinson's disease is a debilitating condition that can show subtle ... Medina explained: "These similarities across ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

On average, they survive for only two to five years after being diagnosed, according to the Centers for Disease Control and Prevention. Scientists at Northwestern and Case Western Reserve ...

Parkinson's disease is a progressive brain disorder that causes nerve cells in the brain to die, leading to a range of ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

As well as tremors being one of its most known symptoms, recent research has found also found other factors like vivid ...